TVF | TechVision Fonds’ Post

Thank you #FrandersBio for the #KFG2024 family reunion! This has been a very busy day discussing and I was happy to be able to join the panel discussion "Biotech Funding: Navigating challenges, exploring solutions" held by our industry investor experts. - the panel view the capital raise for our industry companies, showing robust data, focusing on fundamentals, running close to business plan still with agility, as "back to normal" - they complimented the European companies and acknowledged their ability to do more with limited budget - they also highlighted how challenging the road for fund raising is today: what is the plan beyond the clinical data is key (market, regulatory, milestones reached without spending too much, management team,...) 💡 For those who succeeded, what were the key success-factors? 👉 the science that solve a need 👉 the management team, how open to advices, the trust between the team and VCs 👉 may be luck and most importantly the persistence in building the relationship with VCs, in proving how the challenges were overcame, in bringing responses to feedback ❤️ For all the enjoyable discussions and laughs yesterday, thank you! Vanessa Vankerckhoven Joannes van Cann, PhD Kristiaan Vanhercke Veerle De Colvenaer Sandra Pietri 🍩 Charlotte Wuyts Bernard Miserez Filip Debruyne Tom Torfs Munemasa Sugimoto Sen (Sean) Lin Seppe Seghers Laura Gilbert Sara Schneider-Hamaï #marketneedanalysis #gotomarketstrategy #commercialperformancediagnostic #healthcare

PACE Healthcare Capital says it's "not a unicorn hunter" as it gears up for another fundraise. The fund has not yet received capital commitments, but PACE said it does not expect the fundraise to last more than a year, according to documents submitted to the US SEC. Julia Monfrini Peev Jon David Willingham Nans RIVAT Dr Manmit Bhambra Waverly Deutsch Ling Kung #venturecapital #fundraising #investorrelations #healthcare Read the full story here: https://lnkd.in/e4jvwuSd

More news, hot off the press at Molydyn... we're currently raising our seed round. If you know an investor or VC who might be interested, do get in touch! More details to follow soon. #investment #fundraising #materialsscience

SHS Capital closed the biggest healthcare & life science focused private equity fund in the DACH region ever. This fund is also the 5th biggest private equity fund closed in Germany in 2023. This is partly due to the result of SHS's track record of the last 30 years. Considering all exits of these 30 years we were able to return ~4x the money invested in these companies. This is even more the result of our investors believing in the unique positioning of our team at SHS Capital. Sounds good - for SHS and its investors. But really only for us? We have been able to invest into 4 companies with the new fund so far, increasing the number of portfolio companies to 22. That means 22 innovative healthcare & life science companies that with their products and services provide benefits to patients, their families and society as a whole. Plus as they continue to be successful increase the number of qualified personnel employed. Plus make Europe more resilient and self-sufficient in one of the key industries - healthcare - by building European healthcare champions. 2023 is coming to an end. We are looking forward to 2024. We want to thank everyone in our team for the hard work this year and especially our investors for their trust. #BuildingEuropeanHealthcareChampions CAM Bioceramics B.V. ESSERT Robotics MESI SIMULANDS André Andrés Anna Cornelia Dr. Cornelius David Elisaveta Georg Guillaume Hannes Heike Hubertus Julia Kerstin Lukas Manfred Marie Max Regine Samira Samuel Sarah Stine Uwe

Raising money in early stage Medtech can be challenging. With that it mind, it was great hearing the perspectives of some great investors at AdvaMed's Medtech Conference today — New Enterprise Associates (NEA), KCK Medtech, H.I.G. Capital, and Vensana Capital. Key takeaways: aim for financial VCs over strategics, build sustaining value through disciplined GTM, be prepared for the IPO window to stay narrow, . #Medtech #AdvaMed #fundraising #investors

EUVC #210 with Emma Steele from Ascension VC Listen now (41 mins) | Read on to dive into the Confluence of Profit and Purpose, why fundraising is A Game of Tailored Messaging and a debate of the The Impact and Returns Conundrum 🤔

This is optimal.

Florida's Techno-philanthropy is flourishing with 160 organizations and 40 investors dedicated to societal impact. A majority of these organizations, showcased in the geographic distribution, are deeply involved in Innovation, Technology, and Research, attracting a significant number of impact investors. Some of the companies driving forward innovation in this dynamic industrial ecosystem include Donation Planet, Qgiv, Alpha Sigma Capital, H.I.G. Growth Partners, Hypersphere Ventures, TECHAID Inc, FHRC PROPERTY DEVELOPMENT, L.L.C., Rocket One Capital , ACME Capital, CEAS Investments, Hertz, FIS, Memory Trees. For a deeper dive into Florida’s commitment to technological philanthropy, visit here: https://lnkd.in/gQGDH-qY Regional stakeholders interested in having their own ecosystem mapping platform developed can learn more here: https://lnkd.in/gZbUe6hb #TechForGood #Philanthropy #ImpactInvesting #FloridaNonprofits #InnovationForChange